Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,404,087
  • Shares Outstanding, K 51,624
  • Annual Sales, $ 782,400 K
  • Annual Income, $ 62,700 K
  • 60-Month Beta 1.53
  • Price/Sales 3.01
  • Price/Cash Flow 18.10
  • Price/Book 3.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.45 +23.37%
on 01/27/20
71.19 -7.37%
on 02/21/20
+8.62 (+15.04%)
since 01/21/20
3-Month
50.71 +30.03%
on 11/22/19
71.19 -7.37%
on 02/21/20
+13.53 (+25.82%)
since 11/21/19
52-Week
39.11 +68.60%
on 08/27/19
71.19 -7.37%
on 02/21/20
+2.22 (+3.48%)
since 02/21/19

Most Recent Stories

More News
Emergent (EBS) Earnings Miss in Q4, Revenues Beat Estimates

Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.

TEVA : 13.19 (-0.90%)
SNY : 50.85 (+0.20%)
PRGO : 59.86 (+0.42%)
EBS : 65.94 (+2.11%)
Emergent Biosolu Set to Possibly Pullback After Yesterday's Rally of 7.66%

Emergent Biosolu (NYSE:EBS) traded in a range yesterday that spanned from a low of $63.60 to a high of $71.19. Yesterday, the shares gained 7.7%, which took the trading range above the 3-day high of...

EBS : 65.94 (+2.11%)
Emergent Biosolutions: 4Q Earnings Snapshot

GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported fourth-quarter net income of $46.9 million, after reporting a loss in the same period a year earlier.

EBS : 65.94 (+2.11%)
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019

Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019.

EBS : 65.94 (+2.11%)
Emergent Biosolu Shares Up 11.7% Since SmarTrend's Buy Recommendation (EBS)

SmarTrend identified an Uptrend for Emergent Biosolu (NYSE:EBS) on January 10th, 2020 at $56.82. In approximately 1 month, Emergent Biosolu has returned 11.73% as of today's recent price of $63.48.

EBS : 65.94 (+2.11%)
Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards?

Investors look forward to updates on key drug Endari's expansion plans when Emmaus (EMMA) releases fourth-quarter 2019 results.

BDSI : 5.56 (+5.30%)
EBS : 65.94 (+2.11%)
ASND : 141.90 (-2.21%)
EMMA : 1.8900 (-1.05%)
Emergent BioSolutions to Release Fourth Quarter and Full Year 2019 Financial Results and Conduct a Conference Call on February 20, 2020

Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 20, 2020 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full year 2019, recent...

EBS : 65.94 (+2.11%)
Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for the approval of...

EBS : 65.94 (+2.11%)
Some U.S. Airports Begin Checking Passengers for a Deadly New Chinese Virus

Officials report that passengers from Wuhan, China are now being screened at J.F.K. New York, San Francisco and Los Angeles airports for infection with a mysterious respiratory virus that has killed two...

AEMD : 2.50 (-3.10%)
BMY : 65.63 (+0.71%)
ONCY : 2.63 (+17.94%)
ONC.TO : 3.44 (+18.62%)
EBS : 65.94 (+2.11%)
New Medical Device That is Proving Effective Against the Worlds Toughest Viruses, Including: Ebola, Hep C, HIV, West Nile and Smallpox Wins FDA Designation "Breakthrough Device"

USA News Group - A new study published in the journal Molecular Therapy reports that researchers found a drug used in the treatment of HIV that may also suppress Zika virus infection. Zika virus disease...

AEMD : 2.50 (-3.10%)
NGM : 16.19 (-0.31%)
EBS : 65.94 (+2.11%)
SIGA : 4.73 (-4.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade EBS with:

Business Summary

Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining...

See More

Key Turning Points

2nd Resistance Point 74.69
1st Resistance Point 70.32
Last Price 65.94
1st Support Level 62.44
2nd Support Level 58.93

See More

52-Week High 71.19
Last Price 65.94
Fibonacci 61.8% 58.94
Fibonacci 50% 55.15
Fibonacci 38.2% 51.36
52-Week Low 39.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar